Endoparasitic 2

Miziziziz · 2024 · $11.99 · Action · deal grade D

• Estimated net residual revenue: $608 to $911 per month
• Opportunity: $759 per month at x1.00 dormancy
• Estimated lifetime owners: 20.0k
• 87%% positive across 659 reviews · 8.7 reviews/month

Why it's flagged

• Developer active, last post 7 months ago
• Studio active elsewhere (6 titles tracked), so this one may welcome a partner
• Last build shipped 6 months ago
• Store page localized in only 1 language(s)
• Last discounted 1 months ago, 5 sales in the last 12 months

This case as Markdown · Estimates carry ±30-50%% error per title.